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Abstract 
BACKGROUND: Cutaneous squamous cell carcinoma (SCC) of the hand is the most common soft-tissue 
malignancy in this particular region. A literature survey suggested a higher rate of metastases in advanced SCC 
of the hand compared to head-and-neck cutaneous SCC. 
CASE REPORT: An 84-year-old man presented with an ulcerated firm tumour on the dorsum of his right hand. A 
diagnostic biopsy confirmed the diagnosis SCC. Imaging suggested an involvement of the tendons of digits 3 and 
4. A diagnostic ultrasound suggested a loco-regional axillary lymph node metastasis. After discussion in the 
interdisciplinary tumour board, amputation of the affected digits followed by lymph node excision was 
recommended. 
CONCLUSIONS: Advanced SCC of the hand requires interdisciplinary management. Amputation is part of the 
surgical spectrum in advanced cases. 
 
 
 
 
 
 
 
 
 
 
 
Introduction 
 
Malignant skin tumours of the hand – 
although uncommon-may have a significant impact on 
professional and private life. About 15 % of all soft 
tissue malignancies occur in hand [1]. In a series of 
407 patients cutaneous squamous cell carcinoma 
(SCC) comprised 70.8 % of all malignancies followed 
by basal cell carcinoma and melanoma.  
The predominant localisation was on the 
dorsum of the hand [2], [3]. SCC of the palm is even 
more rarely [4]. Risk factors for SCC on the hand are 
exposed to ultraviolet light, radiation, arsenic or 
immunosuppression, and chronic ulcerations. SCC 
tend to invade subcutaneous adipose tissue, vessels, 
nerve sheaths, tendons, cartilage, and bone. The 5-
year-rate of metastatic disease is about 5% [5].  
Surgery provides a lower relapse rate than 
non-surgical treatment, i.e. 3% versus 33% [3]. A 
multidisciplinary approach is essential to manage the 
advanced disease. Amputation of fingers is rarely 
required but may become unavoidable in advanced 
disease [6]. 
 
 
Case Report 
 
An 84-year-old man presented with an 
ulcerated firm tumour on the dorsum of his right hand. 
He reported that the lesion had been slowly growing 
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for more than two years but started to increase more 
rapidly for three to four months. Since then it became 
ulcerated and showed a tendency of bleeding. His 
medical history was remarkable for diabetes mellitus 
type II and arterial hypertension. 
 
Figure 1: Clinical presentation of an advanced, ulcerated cutaneous 
squamous cell carcinoma of the dorsum of the right hand 
 
On examination, we observed a firm skin 
coloured tumour with central ulceration above the 
metacarpophalangeal joints of the third and fourth 
right digits (Figure 1). The tumour was adherent to 
underlying structures. The size was 4.2 x 3.8 cm. The 
lesion was painful under pressure. 
 
Figure 2: Imaging of the patients; a) X-ray of the hand excluded 
bony tumour involvement; b) MRI of the hand suggested the 
involvement of the tendons digitus 3 and IV; c) Ultrasound image of 
the axillary lymph node metastasis 
A diagnostic biopsy was performed. 
Histopathologic examination revealed a cutaneous 
SCC. The staging was initiated. MRI of the hand 
suggested the involvement of tendons and bony 
structures. Diagnostic ultrasound detected a 
metastatic lymph node in the ipsilateral axilla. No 
distant metastases were detected (Figure 2). 
Laboratory investigations were unremarkable. In the 
interdisciplinary tumour board, a radical surgery with 
amputation of digits III and IV of the right hand was 
suggested followed by regional lymph node 
dissection. 
An interdisciplinary team of hand surgeon and 
dermato-surgeon performed surgery of the primary 
tumour. After preparation of cutaneous palmar flaps, 
the tumour was excised with a safety margin of at 
least 5 mm. The vascular, nervous bundles of the 3
rd
 
and 4
th
 digits were extensively electro-coagulated and 
cut. During metacarpophalangeal amputation, gout 
tophi were found in these joints and surgically 
removed. After preparation of flexor tendons, they 
were shortened and cut. The resulting defect was 
closed by palmar skin flaps (Figure 3). 
 
Figure 3: Surgery of the advanced cancer; a) Marking of the safety 
margins; b) Preparation of the palmar skin flaps; c) Electro-
coagulation of vascular and nervous bundles; d) Exarticulation of 
digit 3 and 4; e) Surgical specimen; f) Suturing of the flaps; g) and 
(h). Palmar and dorsal view 6 days after surgery 
 
Histopathologic examination of the 
amputation specimen demonstrated a desmoplastic 
SCC with a tumour thickness of 11 mm. The 
investigation confirmed an R0 resection with 7 mm 
safety margins. Tumour stage and grading was 
pT2cN1cM0, G2, stage III. Gout tophi were also 
confirmed (Figure 4). In the postoperative care, 
physiotherapy was performed including compression 
therapy and joint mobilisation. After successful and 
uneventful wound healing on the hand, the patient 
underwent axillary lymph node removal in the 
department of surgery.  
  
 
Discussion 
 
Advanced SCC of the hand has a poorer 
prognosis when it occurs in the skin overlying the 
dorsum of the proximal phalanges and web spaces), 
is ulcerated, has a macroscopic diameter greater than 
20 mm, a tumour thickness greater than 4 mm, and an 
invasion to the subcutaneous fat or beyond [2]. 
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Assessment of malignant tumours of the hand 
includes patient’s history, clinical examination, 
imaging with computerised tomography (CT) or 
magnetic resonance imaging (MRI), and diagnostic 
biopsy for histopathology [1]. Since in the present 
patient, histopathology confirmed SCC. A diagnostic 
ultrasound suggested an isolated loco-regional axillary 
lymph node metastasis. The diagnosis of gout trophy 
was a surprise since no clinical or laboratory findings 
indicated a second metabolic disease – diabetes was 
already known and treated. 
Amputation of a digit becomes the treatment 
of choice in case of tumour invasion to the 
periosteum, tumour size > 20 mm, or presence of 
satellite lesions. In a series of 74 patients with SCC on 
the hand, in 5.4 % finger amputation deemed 
necessary [7]. Regional node dissection should be 
performed if there are palpable nodes or imaging 
techniques demonstrating lymph nodes suspicious for 
metastasis [6]. The 5-year metastasis rate of 
cutaneous SCC, in general, has been estimated as 
5%. Standardised effective medical drug therapy is 
yet not available. In a recent study on advanced and 
metastatic cutaneous SCC in general, the overall 
response rate to systemic therapies (mostly epidermal 
growth factor receptor-inhibitors) was 26% with a 
mean duration of response of only 5 months [8]. SCC 
on the hand has a higher propensity for metastases, 
ranging from 6% to 28% [9]. 
In the present case, metacarpophalangeal 
amputation followed by primary defect closure with 
skin flaps, and axillary lymph node dissection were 
performed [10]. The highest cure rates are achieved 
by surgical R0-resection [1]. The relapse rate after 
Mohs surgery is 1.2% [11]. The 5-year-survival rates 
are 88% to 92% for localized disease and 64% for 
advanced disease [12], [13].  
In conclusion, the diagnosis of SCC of the 
hand should not be delayed ensuring the best 
possible treatment outcome. Tumour diagnosis can be 
hampered by other pathologies such as gout trophy in 
the present case. Treatment requires an 
interdisciplinary approach. 
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